Apnea. Other diseases of the respiratory system
Conditions
Interventions
Intervention 1: Intervention group: On the first two days of the study a 0.04 grams of 2%-saturated vanillin solution is used every 12 hours and on the following three days, no vanillin solution is us
Prevention
Intervention group: On the first two days of the study a 0.04 grams of 2%-saturated vanillin solution is used every 12 hours and on the following three days, no vanillin solution is used with no inter
Control group: newborns are likewise under continuous monitoring but with no interventions.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The inclusion criteria: Gestational age<36 weeks; Postnatal age: 2 day old; Birth weigth<2500gr; No need for ventilator; Absence of congenital heart disease. The exclusion criteria: Hypocalcemia; Hypoglycemia;Hb<10; Need for ventilator; Intraventricular hemorrhage during intervention.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of apnea. Timepoint: 2-7 days of postnatal age. Method of measurement: Pulsoximetry.;Heart rate. Timepoint: 2-7 days of postnatal age. Method of measurement: Pulsoximetry.;Oxygen saturation. Timepoint: 2-7 days of postnatal age. Method of measurement: Pulsoximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMrs Mitra Edraki
Shiraz University of Medical Sciences, Fatemeh (P.B.U.H) School of Nursing & Midwifery
Outcome results
None listed